Lv3
400 积分 2024-04-20 加入
Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial
2天前
已完结
Risk of new-onset diabetes with high-intensity statin use
2天前
已完结
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
1个月前
已完结
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
1个月前
已完结
Current status and future trends of the global burden of MASLD
1年前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
1年前
已完结
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
1年前
已完结
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
1年前
已完结
The gut–liver axis and gut microbiota in health and liver disease
1年前
已完结
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
1年前
已完结
皖公网安备34019202002308
